ESMO Breast Cancer 2019: good outcomes in young women with aggressive breast cancer

According to Matteo Lambertini (University of Genoa, Italy), the results of two studies recently presented at the ESMO Breast Cancer Congress 2019 (2–4 May, Berlin, Germany) have suggested that although breast cancer in young women is characterized by more aggressive biological features compared to in older patients, the outcomes are good when guideline-recommended treatments are given.Lambertini highlighted: “Women under 40 years of age tend to be diagnosed with more aggressive breast cancer types – for example their tumors are more likely to be triple negative and HER2 positive. Despite this, survival and local recurrence rates are similar to those of...